IEEE Pulse. 2025 Nov-Dec;16(6):71-74. doi: 10.1109/MPULS.2025.3640869.
ABSTRACT
Jim Clemmer, CEO of AngioDynamics, shares how he transformed the company into a science-driven innovator focused on cancer and cardiovascular disease through bold portfolio changes, deep physician engagement, and a strong market access strategy. His insights highlight the importance of agility, data-driven credibility, and aligning reimbursement early to bring groundbreaking MedTech technologies to market.
PMID:41790848 | DOI:10.1109/MPULS.2025.3640869